Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, Clinical Professor at the Temple University School of Pharmacy, Clinical Pharmacy Specialist in Infectious Diseases at Temple University Hospital and Director of the Postgraduate Year Two Infectious Diseases Residency at the Temple University School of Pharmacy, reflected on the implications of the pharmaceutical company Sanofi obtaining over-the-counter rights for Tamiflu and how that could impact patient care for the February issue of Contagion Live.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH